Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107
Thanh U. Barbie(Brigham and Women's Hospital), Patricia K. Donahoe(Harvard University), David T. MacLaughlin(Harvard University), David A. Barbie(Dana-Farber Cancer Institute), Shyamala Maheswaran(Massachusetts General Hospital)
Cited by 78
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k